Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CODX Co-Diagnostics, Inc.

Pre-Mkt 08-12 06:01:49 EDT

1.49

-0.01

-0.67%

High1.53	Low1.45	Vol161.55K
Open1.52	D1 Closing1.50	Amplitude5.67%
Mkt Cap7.87M	Tradable Cap7.54M	Total Shares5.28M
T/O239.06K	T/O Rate3.19%	Tradable Shares5.06M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CODX","market":"US","secType":"STK","nameCN":"Co-Diagnostics, Inc.","latestPrice":1.49,"timestamp":1786478400000,"preClose":1.5,"halted":0,"volume":161546,"delay":0,"changeRate":-0.006666666666666672,"floatShares":5057530,"shares":5278957,"eps":-29.3895,"marketStatus":"Pre-Mkt","change":-0.01,"latestTime":"08-12 06:01:49 EDT","open":1.52,"high":1.53,"low":1.445,"amount":239058.3070722,"amplitude":0.056667,"askPrice":1.61,"askSize":100,"bidPrice":1.33,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-29.3895,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786541400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.49,"postHourTrading":{"tag":"盘后","latestPrice":1.4603,"preClose":1.49,"latestTime":"19:34 EDT","volume":4891,"amount":7210.0189,"timestamp":1786491244322,"change":-0.0297,"changeRate":-0.019933,"amplitude":0.040268},"volumeRatio":0.4518352152361788,"impliedVol":1.6193,"impliedVolPercentile":0.5657},"requestUrl":"/m/hq/s/CODX","defaultTab":"news","newsList":[{"id":"2658454943","title":"Co-Diagnostics Inc Expected to Post a Loss of $3.00 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658454943","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658454943?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:25","pubTimestamp":1786479905,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc <CODX.OQ> expected to post a loss of $3.00 a share - Earnings PreviewCo-Diagnostics IncCODX.OQCODX.Ois expected to  show a rise in quarterly revenue when it reports  results on August 13 for the period ending June 30 2026The Salt Lake City Utah-based  company is expected to report a 2.1% increase in revenue to $166.5 thousand from $163 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.LSEG's mean analyst estimate for Co-Diagnostics Inc is for a loss of $3.00 per share.The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is no \"strong buy\" or \"buy,\" 2 \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. This summary was machine generated August 11 at 20:25 GMT.  All figures in US dollars unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N44822T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657963229","title":"Co-Diagnostics Submits FDA 510(k) Filing for Flu A/B and RSV Point-of-Care Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2657963229","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657963229?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:32","pubTimestamp":1786023146,"startTime":"0","endTime":"0","summary":"Co-Diagnostics submits FDA 510(k) filing for Flu A/B and RSV point-of-care testCo-Diagnostics filed a Dual FDA 510(k) premarket notification with a concurrent CLIA Waiver by Application for its Co-Dx ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3tmMQ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657994632","title":"Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2657994632","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657994632?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:30","pubTimestamp":1786023000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA8QFMTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4082","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655536676","title":"Co-Diagnostics Holders Exercise 1,702,362 Warrants at USD 1.57 Per Share in Inducement Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2655536676","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655536676?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:31","pubTimestamp":1785501112,"startTime":"0","endTime":"0","summary":"Co-Diagnostics holders exercise 1,702,362 warrants at USD 1.57 per share in inducement dealCo-Diagnostics entered an inducement deal for holders to cash-exercise existing warrants for 1,702,362 shares","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL4dwjsL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655870082","title":"Co-Diagnostics Schedules Q2 2026 Earnings Release and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2655870082","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655870082?lang=en_us&edition=fundamental","pubTime":"2026-07-30 21:03","pubTimestamp":1785416590,"startTime":"0","endTime":"0","summary":"Co-Diagnostics schedules Q2 2026 earnings release and webcastCo-Diagnostics schedules second-quarter 2026 results for Aug. 13, 2026.Conference call, webcast set for Aug. 13, 2026 at 4:30 p.m. ET via i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL1ZJX2C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014001","title":"Co-Diagnostics Affiliate CoSara Sends Saragene Bundibugyo Ebola Test Kits for Third-party Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014001","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014001?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:04","pubTimestamp":1785240286,"startTime":"0","endTime":"0","summary":"Co-Diagnostics affiliate CoSara sends SARAGENE Bundibugyo Ebola test kits for third-party evaluationCo-Diagnostics’ India joint venture CoSara shipped 200 SARAGENE Bundibugyo virus test kits to a thir","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL86dJ1x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654779023","title":"Co-Diagnostics - Amends Equity Distribution Agreement with Maxim Group for Common Stock Sale - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2654779023","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654779023?lang=en_us&edition=fundamental","pubTime":"2026-07-28 05:09","pubTimestamp":1785186594,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43T14W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654023719","title":"Co-Diagnostics Amends Maxim Equity Distribution Agreement, Removes Aggregate Sales Cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2654023719","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654023719?lang=en_us&edition=fundamental","pubTime":"2026-07-28 05:06","pubTimestamp":1785186380,"startTime":"0","endTime":"0","summary":"Co-Diagnostics amends Maxim equity distribution agreement, removes aggregate sales capCo-Diagnostics amended its equity distribution agreement with Maxim, removing the fixed cap on aggregate sales of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL5fp5gw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653471763","title":"Co-Diagnostics' India Joint Venture Launches Clinical Studies for Tuberculosis Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2653471763","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653471763?lang=en_us&edition=fundamental","pubTime":"2026-07-22 21:27","pubTimestamp":1784726864,"startTime":"0","endTime":"0","summary":"Co-Diagnostics  said Wednesday that its CoSara Diagnostics joint venture in India is initiating clinical studies for its tuberculosis test on the CoSara PCR Pro instrument.The company said the CoSara PCR Pro instrument, which is the CoSara-branded version of the Co-Dx PCR Pro point-of-care instrument, is being deployed in select labs across India for tuberculosis testing evaluation.Co-Dx PCR platform products, including PCR test kits and the sample lysis instrument, are expected to be manufactured and distributed in India under the CoSara brand, the company said.The Co-Dx PCR platform and associated tests remain subject to review or authorization by applicable regulatory authorities and are not yet available for sale.Shares of Co-Diagnostics were up more than 8% pre-bell.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JYNT","BK4185","CODX","MNDmain","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653684957","title":"Co-diagnostics - Co-dx Pcr Platform Products to be Manufactured and Distributed in India Under Cosara Brand","url":"https://stock-news.laohu8.com/highlight/detail?id=2653684957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653684957?lang=en_us&edition=fundamental","pubTime":"2026-07-22 21:00","pubTimestamp":1784725205,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA16NFJX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653476846","title":"Co-diagnostics Joint Venture Cosara Initiates Clinical Studies in India for Tuberculosis Test on Pcr Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2653476846","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653476846?lang=en_us&edition=fundamental","pubTime":"2026-07-22 21:00","pubTimestamp":1784725205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA16NFJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653244270","title":"Co-diagnostics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2653244270","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653244270?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:01","pubTimestamp":1784638895,"startTime":"0","endTime":"0","summary":"Co-Diagnostics announces annual shareholder meetingCo-Diagnostics schedules its annual shareholder meeting in Salt Lake City on Sept. 3, 2026.Vote set for five director seats, covering the full board.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL5sbBSg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651442136","title":"Co-diagnostics Names Wes Lindsey Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2651442136","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651442136?lang=en_us&edition=fundamental","pubTime":"2026-07-16 21:03","pubTimestamp":1784207000,"startTime":"0","endTime":"0","summary":"Co-Diagnostics names Wes Lindsey chief scientific officerCo-Diagnostics named Wes Lindsey as chief scientific officer on July 16, 2026.Lindsey has more than 20 years in molecular diagnostics, includin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL9phhWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651425744","title":"Co-diagnostics Appoints Wes Lindsey, Phd, MBA as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2651425744","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651425744?lang=en_us&edition=fundamental","pubTime":"2026-07-16 21:00","pubTimestamp":1784206805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA4NMHX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650118181","title":"Co-diagnostics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2650118181","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650118181?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:05","pubTimestamp":1783677904,"startTime":"0","endTime":"0","summary":"Co-Diagnostics announces annual shareholder meetingCo-Diagnostics will hold its annual shareholder meeting in Salt Lake City on Sept. 3, 2026.Shareholders will vote on electing five directors for one-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL11G17p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648546942","title":"NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2648546942","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648546942?lang=en_us&edition=fundamental","pubTime":"2026-07-01 21:40","pubTimestamp":1782913250,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 09:40 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nAQN2M6GCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648545650","title":"Co-diagnostics Completes Studies Ahead of Planned Q3 2026 FDA Filing for Flu/rsv Point-of-care PCR Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2648545650","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648545650?lang=en_us&edition=fundamental","pubTime":"2026-07-01 21:05","pubTimestamp":1782911124,"startTime":"0","endTime":"0","summary":"Co-Diagnostics completes studies ahead of planned Q3 2026 FDA filing for Flu/RSV point-of-care PCR testCo-Diagnostics completed clinical and analytical studies for its Co-Dx PCR Flu A/B & RSV point-of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL11gkC6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648154300","title":"Co-diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-care Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2648154300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648154300?lang=en_us&edition=fundamental","pubTime":"2026-07-01 21:00","pubTimestamp":1782910810,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nTUA1H32NT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644086950","title":"Co-Diagnostics hosts Saudi joint venture CoMira for automated manufacturing line unveiling in Utah","url":"https://stock-news.laohu8.com/highlight/detail?id=2644086950","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644086950?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:06","pubTimestamp":1781787984,"startTime":"0","endTime":"0","summary":"Co-Diagnostics hosted a delegation from Saudi joint venture CoMira at its Salt Lake City headquarters for a technology and innovation event.The company showcased a planned automated PCR test kit manufacturing line ahead of a technology transfer to support scaled regional production.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL1RR9qq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642372287","title":"Co-Diagnostics Signs Exclusive Distribution Deal With Mexican Partner; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2642372287","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642372287?lang=en_us&edition=fundamental","pubTime":"2026-06-11 21:22","pubTimestamp":1781184169,"startTime":"0","endTime":"0","summary":"Co-Diagnostics  has signed an exclusive distribution agreement with an unnamed partner in Mexico for the Co-Dx PCR point-of-care platform, the company said Thursday.Financial terms were not disclosed.The deal includes the company's PCR Pro instrument and associated test kits, and is part of its efforts to expand its business in Latin America, it said.Shares of Co-Diagnostics were up 3.1% pre-bell.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.codiagnostics.com","stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":-0.4291},{"period":"3month","weight":-0.0688},{"period":"6month","weight":-0.366},{"period":"1year","weight":-0.8033},{"period":"ytd","weight":-0.7054}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0207},{"period":"3month","weight":0.0381},{"period":"6month","weight":0.1311},{"period":"1year","weight":0.2117},{"period":"ytd","weight":0.13}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.280232},{"month":2,"riseRate":0.222222,"avgChangeRate":0.209425},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.179204},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.011372},{"month":5,"riseRate":0.444444,"avgChangeRate":0.541725},{"month":6,"riseRate":0.888889,"avgChangeRate":0.02431},{"month":7,"riseRate":0.555556,"avgChangeRate":0.094133},{"month":8,"riseRate":0.5,"avgChangeRate":-0.056999},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.02377},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.003584},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.082815},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.196965}],"exchange":"NASDAQ","name":"Co-Diagnostics, Inc.","nameEN":"Co-Diagnostics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Co-Diagnostics, Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Co-Diagnostics, Inc.,CODX,Co-Diagnostics, Inc.股票,Co-Diagnostics, Inc.股票老虎,Co-Diagnostics, Inc.股票老虎国际,Co-Diagnostics, Inc.行情,Co-Diagnostics, Inc.股票行情,Co-Diagnostics, Inc.股价,Co-Diagnostics, Inc.股市,Co-Diagnostics, Inc.股票价格,Co-Diagnostics, Inc.股票交易,Co-Diagnostics, Inc.股票购买,Co-Diagnostics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Co-Diagnostics, Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction